| Published Application/Species/Sample/Dilution | Reference |
|---|
| Hu Z, Shi L, Xu N, Wang X, Hu J, Zhao J, et al. Induction of cross-group broadly reactive antibody response by natural H7N9 avian influenza virus infection and immunization with inactivated H7N9 vaccine in chickens. Transbound Emerg Dis. 2020;: pubmed publisher |
- ELISA; H5N1 subtype
- ELISA; H7N9 subtype
- ELISA; H1N1 subtype
| Grodeland G, Fossum E, Bogen B. Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs. Vaccine. 2019;: pubmed publisher |
| Andersen T, Huszthy P, Gopalakrishnan R, Jacobsen J, Fauskanger M, Tveita A, et al. Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules. NPJ Vaccines. 2019;4:9 pubmed publisher |
| Anderson A, Baranowska Hustad M, Braathen R, Grodeland G, Bogen B. Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza. J Immunol. 2018;200:2057-2066 pubmed publisher |
| Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed publisher |
- western blot; H1N1 subtype
| Dai J, Pei D, Wang B, Kuang Y, Ren L, Cao K, et al. A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. Virol J. 2013;10:40 pubmed publisher |
- western blot; H1N1 subtype
| Wu C, Yeh Y, Chan J, Yang Y, Yang J, Liu M, et al. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS ONE. 2012;7:e42363 pubmed publisher |
| Cardon A, Guinebreti xe8 re T, Dong C, Gil L, Ado S, Gavlovsky P, et al. Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting. Nat Commun. 2025;16:1161 pubmed publisher |
| Ko K, Bae H, Park J, Lee J, Park S, Heo J, et al. A vaccine platform targeting lung-resident memory CD4+ T-cells provides protection against heterosubtypic influenza infections in mice and ferrets. Nat Commun. 2024;15:10368 pubmed publisher |
| Wu M, Song G, Li J, Song Z, Zhao B, Liang L, et al. Innervation of nociceptor neurons in the spleen promotes germinal center responses and humoral immunity. Cell. 2024;187:2935-2951.e19 pubmed publisher |
| Li X, Wang H, Lai W, Liao J, Mo W, Huang K, et al. Prevention and treatment of HPV-related cancer through a mRNA vaccine expressing APC-targeting antigen. Immunology. 2024;172:375-391 pubmed publisher |
| Tj xe4 rnhage E, Brown D, Bogen B, Andersen T, Gr xf8 deland G. Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza. J Virol. 2023;97:e0169422 pubmed publisher |
| Wang B, Yang D, Chang Z, Zhang R, Dai J, Fang Y. Wearable bioelectronic masks for wireless detection of respiratory infectious diseases by gaseous media. Matter. 2022;5:4347-4362 pubmed publisher |
| Olukitibi T, Ao Z, Azizi H, Mahmoudi M, Coombs K, Kobasa D, et al. Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines. Front Microbiol. 2022;13:937192 pubmed publisher |
| Gregoire C, Spinelli L, Villazala Merino S, Gil L, Holgado M, Moussa M, et al. Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism. Immunity. 2022;55:1216-1233.e9 pubmed publisher |
| Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, et al. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell. 2022;185:614-629.e21 pubmed publisher |
| Szodoray P, Andersen T, Heinzelbecker J, Imbery J, Huszthy P, Stanford S, et al. Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity. Cell Rep. 2021;36:109525 pubmed publisher |
| Esterly H, Crilly C, Piszkiewicz S, Shovlin D, Pielak G, Christian B. Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice. Front Pharmacol. 2020;11:565969 pubmed publisher |
| Wang M, Huang Y, Gu W, Wang H. Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice. J Vis Exp. 2020;: pubmed publisher |
| Wu G, Yu G, Yu Y, Yang S, Duan Z, Wang W, et al. Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion. J Med Chem. 2020;63:6924-6940 pubmed publisher |
| Grødeland G, Baranowska Hustad M, Abadejos J, Blane T, Teijaro J, Nemazee D, et al. Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin. Front Immunol. 2020;11:431 pubmed publisher |
| Ramírez Salinas G, García Machorro J, Rojas Hernández S, Campos Rodríguez R, De Oca A, Gomez M, et al. Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies. Arch Virol. 2020;165:891-911 pubmed publisher |
| Luganini A, Terlizzi M, Catucci G, Gilardi G, Maffei M, Gribaudo G. The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin. Front Microbiol. 2018;9:1826 pubmed publisher |
| Pardi N, Hogan M, Naradikian M, Parkhouse K, Cain D, Jones L, et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018;215:1571-1588 pubmed publisher |
| Mendoza M, Ballesteros A, Qi Q, Sang L, Shashikumar S, Casares S, et al. Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2R?c KO. NOD). Hum Vaccin Immunother. 2017;: pubmed publisher |
| Andersen T, Zhou F, Cox R, Bogen B, Grødeland G. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza. J Virol. 2017;91: pubmed publisher |
| Magnen M, Gueugnon F, Guillon A, Baranek T, Thibault V, Petit Courty A, et al. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs. J Virol. 2017;91: pubmed publisher |
| Gupta N, Lainson J, Domenyuk V, Zhao Z, Johnston S, Diehnelt C. Whole-Virus Screening to Develop Synbodies for the Influenza Virus. Bioconjug Chem. 2016;27:2505-2512 pubmed |
| Shembekar N, Mallajosyula V, Mishra A, Yeolekar L, Dhere R, Kapre S, et al. Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site. PLoS ONE. 2013;8:e55516 pubmed publisher |
| Hütter J, Rödig J, Höper D, Seeberger P, Reichl U, Rapp E, et al. Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity. J Immunol. 2013;190:220-30 pubmed publisher |
| Dai J, Pei D, Wang B, Kuang Y, Ren L, Cao K, et al. Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination. Viruses. 2012;4:3606-24 pubmed publisher |
